- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 473/30 - Oxygen atom attached in position 6, e.g. hypoxanthine
Patent holdings for IPC class C07D 473/30
Total number of patents in this class: 168
10-year publication summary
|
15
|
11
|
15
|
15
|
9
|
5
|
11
|
6
|
7
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BeiGene, Ltd. | 370 |
9 |
| Genentech, Inc. | 3994 |
7 |
| SHY Therapeutics LLC | 30 |
7 |
| Amgen Inc. | 4106 |
6 |
| Medivir AB | 122 |
6 |
| Impetis Biosciences Ltd. | 29 |
6 |
| Merck Sharp & Dohme LLC | 3760 |
5 |
| F. Hoffmann-La Roche AG | 7941 |
4 |
| Merck Sharp & Dohme Corp. | 2191 |
4 |
| Takeda Pharmaceutical Company Limited | 2705 |
3 |
| ATIR Holding S.A. | 18 |
3 |
| Auburn University | 508 |
3 |
| Tango Therapeutics, Inc. | 49 |
3 |
| Novartis AG | 10730 |
2 |
| The Regents of the University of California | 20059 |
2 |
| AstraZeneca AB | 2908 |
2 |
| Commissariat à l'énergie atomique et aux energies alternatives | 10941 |
2 |
| Consejo Superior de Investigaciones Cientificas (csic) | 1373 |
2 |
| Eli Lilly and Company | 3878 |
2 |
| Gilead Sciences, Inc. | 2045 |
2 |
| Other owners | 88 |